A potential relation might lie in CD36 cells, whose deficiency was known to aggravate hepatic steatosis severity due to decreased FFA oxidation and, together with adiponectin, make a two-way direction in terms of potentiating their activity when it comes to the FFA oxidation process. Here, CD36 is linked to fatty liver disease.